Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Tesirine intermediate-1 | 1430738-05-8 | 99.4% | C28H48N2O7Si2 | 250 MG
SDP

Catalog No. 5000357646
Encompass_Preferred

Tesirine intermediate-1 is an intermediate in the synthesis of Tesirine, a pyrrole benzodiazepine (PBD) dimer that acts as a DNA small channel crosslinker. This compound exhibits strong cytotoxicity and is utilized for synthesizing Antibody-Drug Conjugates (ADCs) whose payloads demonstrate potent anticancer cell activity.

  • Intermediate for advanced chemical synthesis
  • Functions as a pyrrole benzodiazepine (PBD) dimer
  • Acts as a DNA small channel crosslinker
  • Exhibits strong cytotoxicity
  • Key component for Antibody-Drug Conjugate (ADC) synthesis
  • Payloads demonstrate potent anticancer cell activity

Catalog No. 50-003-57646 Supplier Medchemexpress LLC Supplier No. 250MGHY47820
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Tesirine intermediate-1 is an intermediate in the synthesis of Tesirine, a pyrrole benzodiazepine (PBD) dimer that acts as a DNA small channel crosslinker. This compound exhibits strong cytotoxicity and is utilized for synthesizing Antibody-Drug Conjugates (ADCs) whose payloads demonstrate potent anticancer cell activity.

  • Intermediate for advanced chemical synthesis
  • Functions as a pyrrole benzodiazepine (PBD) dimer
  • Acts as a DNA small channel crosslinker
  • Exhibits strong cytotoxicity
  • Key component for Antibody-Drug Conjugate (ADC) synthesis
  • Payloads demonstrate potent anticancer cell activity

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.